These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39195215)

  • 1. Immune Control of Human Cytomegalovirus (HCMV) Infection in HCMV-Seropositive Solid Organ Transplant Recipients: The Predictive Role of Different Immunological Assays.
    Zavaglio F; Cassaniti I; d'Angelo P; Zelini P; Comolli G; Gregorini M; Rampino T; Del Frate L; Meloni F; Pellegrini C; Abelli M; Ticozzelli E; Lilleri D; Baldanti F
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients.
    Zavaglio F; Rivela F; Cassaniti I; Arena F; Gabanti E; Asti AL; Lilleri D; Rampino T; Baldanti F; Gregorini M
    J Med Virol; 2023 Feb; 95(2):e28507. PubMed ID: 36655741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli.
    Gabanti E; Bruno F; Scaramuzzi L; Mangione F; Zelini P; Gerna G; Lilleri D
    New Microbiol; 2016 Oct; 39(4):247-258. PubMed ID: 27727404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the T-cell response to human cytomegalovirus (HCMV) as detected by cytokine flow cytometry and QuantiFERON-CMV assay in HCMV-seropositive kidney transplant recipients.
    Gabanti E; Lilleri D; Scaramuzzi L; Zelini P; Rampino T; Gerna G
    New Microbiol; 2018 Jul; 41(3):195-202. PubMed ID: 30028473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inconsistent responses of cytomegalovirus-specific T cells to pp65 and IE-1 versus infected dendritic cells in organ transplant recipients.
    Lilleri D; Zelini P; Fornara C; Comolli G; Gerna G
    Am J Transplant; 2007 Aug; 7(8):1997-2005. PubMed ID: 17617865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyfunctional analysis of human cytomegalovirus (HCMV)-specific CD4(+) and CD8 (+) memory T-cells in HCMV-seropositive healthy subjects following different stimuli.
    Gabanti E; Bruno F; Fornara C; Bernuzzi S; Lilleri D; Gerna G
    J Clin Immunol; 2014 Nov; 34(8):999-1008. PubMed ID: 25231588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.
    Gabanti E; Bruno F; Lilleri D; Fornara C; Zelini P; Cane I; Migotto C; Sarchi E; Furione M; Gerna G
    PLoS One; 2014; 9(8):e106044. PubMed ID: 25166270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation.
    Gerna G; Lilleri D; Fornara C; Comolli G; Lozza L; Campana C; Pellegrini C; Meloni F; Rampino T
    Am J Transplant; 2006 Oct; 6(10):2356-64. PubMed ID: 16889599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELISPOT assay of interferon-γ secretion for evaluating human cytomegalovirus reactivation risk in allo-HSCT recipients.
    Liang H; Xia J; Zhang R; Yang B; Wu J; Gui G; Huang Y; Chen X; Yang R; Wang H; Gong S; Fan J
    J Med Virol; 2021 Nov; 93(11):6301-6308. PubMed ID: 34076905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus-specific CD4(+) and CD8(+) T-cell response determination: comparison of short-term (24h) assays vs long-term (7-day) infected dendritic cell assay in the immunocompetent and the immunocompromised host.
    Zelini P; Lilleri D; Comolli G; Rognoni V; Chiesa A; Fornara C; Locatelli F; Meloni F; Gerna G
    Clin Immunol; 2010 Aug; 136(2):269-81. PubMed ID: 20493777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
    Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic and local human cytomegalovirus-specific T-cell response in lung transplant recipients.
    Lilleri D; Gerna G; Bruno F; Draghi P; Gabanti E; Fornara C; Meloni F
    New Microbiol; 2013 Jul; 36(3):267-77. PubMed ID: 23912868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.
    Nemeckova S; Krystofova J; Babiarova K; Hainz P; Musil J; Sroller V; Maly M; Stastna-Markova M
    Transpl Infect Dis; 2016 Jun; 18(3):381-9. PubMed ID: 27061389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Cytomegalovirus (HCMV)-Specific CD4
    Jackson SE; Sedikides GX; Mason GM; Okecha G; Wills MR
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
    J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
    Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
    J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation.
    Gerna G; Lilleri D; Chiesa A; Zelini P; Furione M; Comolli G; Pellegrini C; Sarchi E; Migotto C; Bonora MR; Meloni F; Arbustini E
    Am J Transplant; 2011 Nov; 11(11):2463-71. PubMed ID: 21827612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants.
    Abate D; Saldan A; Forner G; Tinto D; Bianchin A; Palù G
    J Virol Methods; 2014 Feb; 196():157-62. PubMed ID: 24216234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Cytomegalovirus-Specific Memory CD4+ T-Cell Response and Its Correlation With Virus Transmission to the Fetus in Pregnant Women With Primary Infection.
    Fornara C; Cassaniti I; Zavattoni M; Furione M; Adzasehoun KMG; De Silvestri A; Comolli G; Baldanti F
    Clin Infect Dis; 2017 Oct; 65(10):1659-1665. PubMed ID: 29020188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.